Blue Rock Advisors’s Medtronic MDT Stock Holding History

Blue Rock Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-85,267	Closed	-$8.86M	–	68
2020 Q3	$8.86M	Buy	+85,267	New	+$8.56M	7.65%	1

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Rock Advisors's MDT Position: Q4 2020 in Review

Blue Rock Advisors sold out of Medtronic (MDT) in Q4 2020, closing a stake of 85,267 shares — an estimated $8.86M sold.

Blue Rock Advisors first reported a position in MDT in Q3 2020 and held it in 1 quarter. The position peaked at $8.86M in Q3 2020. 1,958 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

Blue Rock Advisors reported no remaining Medtronic position as of Q4 2020 after selling out during the quarter.
Blue Rock Advisors sold 85,267 Medtronic shares in Q4 2020, an estimated $8.86M.
Blue Rock Advisors first reported a position in Medtronic in Q3 2020 and held it in 1 quarter.
Blue Rock Advisors's Medtronic position peaked at $8.86M in Q3 2020.
1,958 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on Blue Rock Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.